This inventor holds 2 USPTO granted patents. Top assignee: Biofrontera Bioscience Gmbh. Active years: 2006-2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006-2009
Title: Christoph Ullmer: Innovator in Medicinal Chemistry
Introduction: Christoph Ullmer is a notable inventor based in Bergisch Gladbach, Germany. He has made significant contributions to the field of medicinal chemistry, particularly in the development of novel pharmaceutical compounds. With a total of two patents to his name, Ullmer's work focuses on innovative solutions for medical treatments.
Latest Patents: Ullmer's latest patents involve derivatives of 4-(Thio- or Selenoxanthene-9-ylidene)-piperidine or acridine and their pharmaceutically acceptable salts. These compounds are designed for use as medicaments and for the manufacture of medications aimed at treating disease states that can be alleviated by 5-HT2B antagonists.
Career Highlights: Christoph Ullmer is currently associated with Biofrontera Bioscience GmbH, where he continues to advance his research and development efforts. His expertise in medicinal chemistry has positioned him as a key player in the pharmaceutical industry.
Collaborations: Throughout his career, Ullmer has collaborated with esteemed colleagues such as Hermann Lubbert and Emile M Bellott. These partnerships have fostered a collaborative environment that enhances innovation and the development of new therapeutic solutions.
Conclusion: Christoph Ullmer's contributions to medicinal chemistry and his innovative patents underscore his role as a significant inventor in the pharmaceutical field. His ongoing work
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile